Send to

Choose Destination
See comment in PubMed Commons below
Bioorg Med Chem. 1996 Apr;4(4):531-6.

Ophiobolin M and analogues, noncompetitive inhibitors of ivermectin binding with nematocidal activity.

Author information

Department of Cell Biochemistry and Physiology, Merck Research Laboratories, Rahway, NJ 07065, USA.


A series of ophiobolins were isolated from a fungal extract based on their nematocidal activity. These compounds are non-competitive inhibitors of ivermectin binding to membranes prepared from the free-living nematode, Caenorhabditis elegans, with an inhibition constant of 15 microM. The ophiobolins which were most potent in the biological assays, ophiobolin C and ophiobolin M, were also the most potent compounds when evaluated in a C. elegans motility assay. These data suggest that the nematocidal activity of the ophiobolins is mediated via an interaction with the ivermectin binding site. The isolation, structure and biological activity of ophiobolins have been described.

[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Support Center